Compare CVS & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVS | BSX |
|---|---|---|
| Founded | 1963 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.2B | 103.6B |
| IPO Year | 1994 | 2010 |
| Metric | CVS | BSX |
|---|---|---|
| Price | $73.39 | $62.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 21 |
| Target Price | $94.61 | ★ $104.48 |
| AVG Volume (30 Days) | 6.2M | ★ 13.4M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.62% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | 1.39 | ★ 1.94 |
| Revenue | ★ $402,067,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $2.44 | $12.02 |
| Revenue Next Year | $4.47 | $10.41 |
| P/E Ratio | $52.89 | ★ $32.33 |
| Revenue Growth | 7.85 | ★ 12.49 |
| 52 Week Low | $58.35 | $61.25 |
| 52 Week High | $85.15 | $109.50 |
| Indicator | CVS | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 47.67 | 27.95 |
| Support Level | $72.97 | N/A |
| Resistance Level | $80.89 | $76.77 |
| Average True Range (ATR) | 1.83 | 1.91 |
| MACD | 0.08 | -0.38 |
| Stochastic Oscillator | 52.61 | 14.73 |
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.